Omega Diagnostics Group PLC announces launch of VISITECT® CD4 point-of-care test
medrev 2017-04-26T12:35:16+00:00Omega Diagnostics Group PLC has announced the imminent launch of VISITECT® CD4, a ground-breaking point-of-care (POC) disposable test for the detection of CD4 T-cell levels, aimed at reaching HIV-positive patients across the globe. VISITECT® CD4, developed by the Burnet Institute in Melbourne, Australia, is an affordable POC test that enables CD4 T-cell levels to be determined, quickly [...]
